Postacute sequelae of SARS-CoV2 (PASC) infection is an emerging global health crisis, variably affecting millions worldwide. PASC has no established treatment. We describe 2 cases of PASC in response to opportune administration of over-the-counter antihistamines, with significant improvement in symptoms and ability to perform activities of daily living. Future studies are warranted to understand the potential role of histamine in the pathogenesis of PASC and explore the clinical benefits of antihistamines in the treatment of PASC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820139 | PMC |
| http://dx.doi.org/10.1016/j.nurpra.2021.12.016 | DOI Listing |
Publication Analysis
Top Keywords
postacute sequelae
8
pasc
5
antihistamines postacute
4
sequelae sars-cov-2
4
sars-cov-2 infection
4
infection postacute
4
sequelae sars-cov2
4
sars-cov2 pasc
4
pasc infection
4
infection emerging
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!